Tumor necrosis factor-a inhibition and palmoplantar pustulosis: Janus-faced therapy?
Dutz
Jan P
JP
D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D015536:Down-Regulation; D006801:Humans; D011565:Psoriasis / Q000209:etiology / Q000378:metabolism*; D012216:Rheumatic Diseases / Q000188:drug therapy* / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000378:metabolism*
D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha